Tarsons Products Q1 FY27 Results: Revenue Rs 110 Cr, Net Loss Rs 1.00 Cr and Key Highlights

Tarsons Products Q1 FY27 results were declared on August 10, 2026 on a consolidated basis. Revenue expanded +20.66% YoY to Rs 110 Cr from Rs 91 Cr in Q1 FY26. The broader BSE Healthcare index reflected mixed sentiment during the quarter.

Operating profit stood at Rs -1.00 Cr (-121.77% YoY). The company reported a net loss of Rs 1.00 Cr, providing the key financial picture for Tarsons Products Q1 FY27 results.

Click Here – Get Free Investment Predictions

Tarsons Products Q1 FY27 Financial Highlights

Metric	Q1 FY27 (Rs Cr)	Q1 FY26 (Rs Cr)	YoY Change
Tarsons Products Revenue	110	91	+20.66%
Operating Profit	-1.00	4.00	-121.77%
Net Profit (PAT)	-1.00	1.00	-180.99%
Reporting Basis	Consolidated

Tarsons Products Q1 FY27 Performance Analysis

Check the Univest Screener for Live Data on This Stock

Tarsons Products Q1 FY27 results reflect under-pressure fundamentals. Revenue momentum were evident with the top line reaching Rs 110 Cr for the April to June 2026 quarter.

Operating profit contracted -121.77% YoY. Net loss of Rs 1.00 Cr indicates recovery is still in progress. Investors tracking Tarsons Products Q1 FY27 results will note these as key FY27 milestones.

Key Business Factors in Tarsons Products Q1 FY27 Results

Revenue Expansion in Q1 FY27

Tarsons Products Q1 FY27 results show revenue expanding +20.66% YoY to Rs 110 Cr from Rs 91 Cr in Q1 FY26. Volume-led growth and market share gains in the Healthcare/Lab segment drove the uptick.

Margin Pressure from Cost Headwinds

Operating profit in Tarsons Products Q1 FY27 results stood at Rs -1.00 Cr (-121.77% YoY). Input cost inflation and competitive dynamics weighed on operating profitability.

Net Loss and Recovery Roadmap

Net loss of Rs 1.00 Cr in Tarsons Products Q1 FY27 results highlights near-term headwinds. Management is implementing cost optimisation and revenue scaling to return to profitability.

Dividend Details

No dividend was declared alongside Tarsons Products Q1 FY27 results. Earnings are being channelled toward operational reinvestment and working capital.

FY27 Outlook for Tarsons Products

Following Tarsons Products Q1 FY27 results, management has focused on a recovery-driven strategy centred on cost reduction, revenue diversification, and return to profitability in the healthcare/lab segment. Investors tracking Tarsons Products Q1 FY27 results should consult a SEBI-registered financial advisor.

Tarsons Products Stock Performance After Q1 FY27 Results

Download the Univest iOS App or Univest Android App to track Tarsons Products live price and get daily stock recommendations.

Tarsons Products shares were trading higher at Rs 313.5 (+0.38%) on August 10, 2026, reflecting investor sentiment on Tarsons Products Q1 FY27 results and the near-term sector outlook. The CMP of Rs 313.5 on the results date reflects broader sentiment toward the healthcare/lab space.

Key Risks for Tarsons Products

Sector-Specific Risks

Lab equipment demand linked to hospital capex cycles and import competition.

Valuation and Earnings Risk

Sustained margin compression and limited near-term earnings visibility may delay re-rating.

Operational and Financial Risk

Subsidiary-level underperformance could drag consolidated PAT lower in subsequent quarters.

Conclusion

Tarsons Products Q1 FY27 results highlight near-term challenges with revenue at Rs 110 Cr and a net loss of Rs 1.00 Cr on a Consolidated basis. Execution of the recovery plan will be the key catalyst to watch in coming quarters.

Frequently Asked Questions on Tarsons Products Q1 FY27 Results

When were Tarsons Products Q1 FY27 results declared?

Ans. Tarsons Products Q1 FY27 results were declared on August 10, 2026, covering the April–June 2026 quarter on a Consolidated basis.

What was Tarsons Products revenue in Q1 FY27?

Ans. Revenue in Tarsons Products Q1 FY27 results was Rs 110 Cr, +20.66% YoY from Rs 91 Cr in Q1 FY26.

What was Tarsons Products PAT in Q1 FY27?

Ans. Net loss in Tarsons Products Q1 FY27 results was Rs 1.00 Cr (-180.99% YoY).

Did Tarsons Products declare a dividend in Q1 FY27?

Ans. No dividend was announced alongside Tarsons Products Q1 FY27 results. Refer to official NSE and BSE announcements for future dividend updates.

What is the FY27 outlook for Tarsons Products?

Ans. Management has guided operational restructuring and return to profitability for FY27. Sector demand and execution will be key monitorables.

How did Tarsons Products stock react to Q1 FY27 results?

Ans. Tarsons Products shares were higher at Rs 313.5 (+0.38%) on August 10, 2026. Consult a SEBI-registered financial advisor before acting on price movements.